Cite
HARVARD Citation
Dogan, E. et al. (2020). Efficacy of second-line targeted agents in kras wild metastatic colorectal cancer patients who received prior targeted agent: First anti-epidermal growth factor receptor or vascular endothelial growth factor in right and left colon?. Journal of oncology pharmacy practice. pp. 781-786. [Online].